BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (NYSE Alternext US:RGN) announced today that J.J. Finkelstein, RegeneRx’s president and chief executive officer, will present a company update at the 11th Annual BIO CEO & Investor Conference in New York, on Monday, February 9, 2009 at 3:45 p.m. ET. To listen and view the presentation investors may either visit RegeneRx’s homepage at www.regenerx.com or click on the following link:
